Primer composition, sequencing library, method and device for identifying target strain

Through the combination of specific and inclusive primers, the primer specificity and amplicon length problems of non-tuberculous M. tuberculosis species identification were solved, and the high accuracy identification of Mycobacterium was achieved, and the resolution and identification were improved. Accuracy of the results.

CN118932090APending Publication Date: 2024-11-12ZHUHAI GENDOW BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410995752.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art has difficulty in sequencing caused by low primer specificity and excessive amplicon length in the identification of non-tuberculous Mycobacterium species, resulting in misdiagnosis of the disease and drug use errors.

Method used

Using a combination of specific primers and inclusive primers, nucleic acid samples to be tested in complex backgrounds are specifically amplified, which reduces the proportion of non-specific amplicons and increases the specific amplification of mycobacteria that can identify sub-occupation, thereby achieving the identification of mycobacterium from the "species level".

Benefits of technology

It improves the resolution and accuracy of mycobacterium identification, can effectively distinguish different types of non-tuberculous mycobacterium, and reduces misdiagnosis and medication errors.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118932090A_ABST
    Figure CN118932090A_ABST
Patent Text Reader

Abstract

The invention relates to a primer composition, a sequencing library, a method and a device for identifying a target strain. The primer composition comprises a specific primer and an inclusive primer, the specific primer is used for specifically amplifying a specific region of a target strain, and the specific region comprises an intra-genus conserved region of the target strain; the inclusive primer is capable of binding to an intra-genus conserved region in the specific region. According to the application, a mode of combining the specific primer and the inclusive primer is creatively adopted to amplify the nucleic acid sample of the strain to be detected, so that the proportion of non-specific amplicons in an amplification product is greatly reduced, and the proportion of specific amplicons is increased, thereby improving the resolution ratio of strain detection and the accuracy of strain identification.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of bioinformatics, and in particular to a primer composition, a sequencing library, a method and a device for identifying a target bacterial species. Background Art

[0002] Non-tuberculous mycobacteria (NTM) refers to a large class of mycobacteria other than the tuberculosis complex (including human tuberculosis, bovine tuberculosis, African vole tuberculosis, goat tuberculosis, etc.) and Mycobacterium leprae. With the advancement of detection technology, more and more types of non-tuberculous mycobacteria have been identified. So far, more than 190 species and 14 subspecies of NTM have been discovered, most of which are parasitic bacteria, and only a small number of them are pathogenic to humans and are conditionally pathogenic bacteria.

[0003] NTM disease refers specifically to human infection with NTM, and NTM disease has been increasing rapidly in recent years. There are many types of NTM bacteria, which can be divided into two major categories, fast-growing and slow-growing, according to different classification rules, or divided into several categories, such as color-producing and non-color-producing, based on colony morphology and the relationship between pigment production and light reaction. Different NTM bacterial infections cause similar symptoms in patients, which are also very similar to tuberculosis patients. However, the treatment plans for diseases caused by different mycobacterium infections are completely different, and the resulting misdiagnosis or medication errors often plague clinicians and patients. Identification of nontuberculous mycobacterium species before diagnosis and treatment can implement targeted treatment plans for different mycobacterium infections.

[0004] In bacterial species identification, specific primers are usually designed to analyze the differences in the composition of homologous DNA sequences to identify bacteria to the species level, which is the current "gold standard" for bacterial species identification. However, due to the short read length of the second-generation sequencing, the conventional single-end is less than 150bp, and primers can only be designed within 150bp on both sides of the target region for the NTM target region, and the primer specificity is often not high.

[0005] Therefore, identification of nontuberculous mycobacterial species is a difficult point in studying NTM diseases. Summary of the invention

[0006] In order to solve the above problems and realize the identification of non-tuberculous mycobacteria, the first object of the present application is to provide a primer composition for identifying target bacterial species, including: specific primers and inclusive primers; the specific primers are used to specifically amplify the specific region of the target bacterial species, the specific region includes the conserved region within the genus of the target bacterial species, and the inclusive primers can bind to the conserved region within the genus in the specific region.

[0007] The present application creatively adopts a combination of specific primers and inclusive primers to perform specific amplification on nucleic acid samples of the bacterial species to be tested in complex backgrounds such as sputum samples, greatly reducing the proportion of non-specific amplicons in the amplification products and increasing the proportion of specific amplicons that can identify mycobacteria, thereby achieving the identification of mycobacteria from the "species level".

[0008] In one embodiment, the target bacterial species include at least one of Mycobacterium tuberculosis and non-tuberculous mycobacteria;

[0009] Optionally, the specific region includes at least one of a 16S rRNA gene region, a 16S-23S rRNA intergenic region, a 23S rRNA gene region, an rpoB gene region, and a heat shock protein 65 gene region of the target bacterial species;

[0010] Optionally, the length of the fragment amplified by the specific primer is greater than 300 bp;

[0011] Optionally, the length of the amplified fragment of the inclusive primer is less than 300 bp;

[0012] Optionally, the specific primers include a specific upstream primer as shown in SEQ ID No.1 and a specific downstream primer as shown in SEQ ID No.2;

[0013] Optionally, the inclusive primers include at least one of an inclusive upstream primer as shown in SEQ ID No. 3 and an inclusive downstream primer as shown in SEQ ID No. 4;

[0014] Optionally, the sequence of the specific primer is linked to a first universal sequence;

[0015] Optionally, the sequence of the inclusive primer is linked to a second universal sequence.

[0016] The second object of the present application is to provide a method for constructing a sequencing library, comprising:

[0017] A nucleic acid sample of the bacterial species to be tested is obtained, and the nucleic acid sample of the bacterial species to be tested is amplified using the primer combination.

[0018] In one embodiment, using the primer combination to amplify the nucleic acid sample of the test bacterial species includes:

[0019] Amplifying the nucleic acid sample of the tested bacterial species using specific primers to obtain a first amplification product;

[0020] The first amplification product and the inclusive primer are mixed and amplified to obtain a second amplification product;

[0021] Optionally, the method further comprises amplifying the first amplification product and / or the second amplification product using an adapter primer, wherein the adapter primer can bind to the first universal sequence and / or the second universal sequence; or

[0022] The primer composition amplifies the nucleic acid sample of the strain to be tested, comprising:

[0023] Amplifying the nucleic acid sample of the tested bacterial species using specific primers to obtain a first amplification product;

[0024] The first amplification product, at least one of the inclusive primers and the adapter primer are mixed and then amplified.

[0025] The third object of the present application is to provide a sequencing method, comprising: obtaining a sequencing library of the bacterial species to be tested, wherein the sequencing library is constructed using the above method;

[0026] The sequencing library of the bacterial species to be tested is sequenced to obtain sequencing data of the bacterial species to be tested.

[0027] The fourth object of the present application is to provide a method for identifying a target bacterial species, comprising: obtaining sequencing data of the bacterial species to be tested, the sequencing data being obtained according to the above sequencing method;

[0028] Determine the type of bacterial species to be tested based on the sequencing data.

[0029] In one embodiment, determining the type of the strain to be tested based on the sequencing data includes:

[0030] Obtain target reads that are uniquely aligned to the target gene region based on sequencing data;

[0031] The type of the bacterial species to be tested is determined according to the sequence of the target reads, the target gene region includes at least one of the 16S RNA gene region, the 16S-23S rRNA gene region, the 23S rRNA gene region, the rpoB gene region and the heat shock protein 65 gene region of the target bacterial species, and the target bacterial species includes at least one of Mycobacterium tuberculosis and non-tuberculous mycobacteria.

[0032] The fifth object of the present application is to provide a device for identifying target bacteria, comprising:

[0033] Sequencing data acquisition module: used to obtain sequencing data of the strain to be tested, and the sequencing data is obtained according to the above sequencing method;

[0034] Bacterial species identification module: used to determine the type of bacterial species to be tested based on sequencing data.

[0035] The present application also relates to a computer device, comprising a memory and a processor, wherein the memory stores a computer program, and the processor implements the steps of the above method when executing the computer program.

[0036] The present application also relates to a computer-readable storage medium on which a computer program is stored, and when the computer program is executed by a processor, the steps of the above method are implemented.

[0037] The present application also relates to a computer program product, comprising a computer program, which implements the steps of the above method when executed by a processor. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] In order to more clearly illustrate the specific implementation methods of the present application or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.

[0039] Figure 1 A flowchart of a method for identifying a target bacterial species provided in one embodiment of the present application;

[0040] Figure 2 A structural block diagram of a device for identifying target bacteria species provided in one embodiment of the present application;

[0041] Figure 3 An internal structure diagram of a computer device provided in one embodiment of the present application;

[0042] Figure 4 A schematic diagram of the sequence of the specific region provided in Example 1 of the present application;

[0043] Figure 5 The electrophoresis results of the amplification products of the specific primers of multiple samples provided in Example 2 of the present application;

[0044] Figure 6 The electrophoresis results of the amplification products of the inclusive primers of multiple samples provided in Example 2 of the present application;

[0045] Figure 7 This is a schematic diagram of the two-round PCR amplification provided in Example 3 of the present application. DETAILED DESCRIPTION

[0046] References to embodiments of the present application will now be provided in detail, one or more examples of which are described below. Each example is provided as an explanation rather than a limitation of the present application. In fact, it will be apparent to those skilled in the art that various modifications and variations may be made to the present application without departing from the scope or spirit of the present application. For example, a feature described or described as part of one embodiment may be used in another embodiment to produce a further embodiment.

[0047] Therefore, it is intended that the present application covers such modifications and variations that fall within the scope of the appended claims and their equivalents. Other objects, features and aspects of the present application are disclosed in or are apparent from the following detailed description. It will be appreciated by those of ordinary skill in the art that this discussion is merely a description of exemplary embodiments and is not intended to limit the broader aspects of the present application.

[0048] For mycobacteria, if specific primers cannot be designed, when identifying mycobacterial resistance, sputum culture is often performed first to exclude other interfering microorganisms before molecular resistance detection and identification. Bacterial culture is time-consuming and labor-intensive, and the production of some strains is calculated on a monthly basis, which seriously affects the output of resistance results and causes great trouble to patients and doctors.

[0049] In order to solve at least one of the above-mentioned technical problems, the first aspect of the present application provides a primer composition for identifying a target bacterial species, comprising: a specific primer and an inclusive primer; the specific primer is used to specifically amplify a specific region of the target bacterial species, the specific region includes a conserved region within the genus of the target bacterial species, and the inclusive primer can bind to the conserved region within the genus in the specific region.

[0050] In the present application, "specific primers" refer to primers that can specifically amplify mycobacteria to distinguish and identify mycobacteria from non-mycobacteria, and the amplification region of the specific primer, i.e., the specific region, contains the conserved region within the genus of mycobacterium, so that the inclusive primers can amplify the genomes of multiple types of mycobacteria.

[0051] In the present application, "inclusive primers" refer to primers that can amplify the genome of mycobacteria and detect mycobacteria, and "inclusive primers" can bind to the conserved region within the genus in the specific region of the target bacteria and amplify the specific regions of multiple types of mycobacteria.

[0052] It is understandable that the specific primer and the inclusive primer can be the same sequence or different sequences. If the specific primer can meet both the specificity and the inclusive primer sequence requirements, the specific primer and the inclusive primer are combined into one. If the "inclusive primer" can ensure the specific detection of mycobacteria, the "inclusive primer" can also be used as a "specific primer".

[0053] The present application found that for mycobacterium identification, when designing primers for mycobacterium-specific regions, there is not only the problem of low specificity of inclusive primers leading to more nonspecific amplification, but also the problem of specific primer amplicons being larger than 300bp and difficult to be fully detected by second-generation sequencing.

[0054] The present application creatively adopts a combination of specific primers and inclusive primers to amplify the nucleic acid sample of the test bacterial species, greatly reducing the proportion of non-specific amplicons in the amplification product and increasing the proportion of specific amplicons that can identify mycobacteria, thereby improving the resolution of mycobacterium identification and realizing the identification of mycobacteria from the "species level" and the identification of non-tuberculous mycobacteria of different types.

[0055] Therefore, in some embodiments, the amplified fragment length of the specific primer is greater than 300bp, and the amplified fragment length of the inclusive primer is less than 300bp. It is understandable that for specific primers with an amplified fragment less than 300bp, the resolution of the "species level" identification of mycobacteria and the detection of different typings of non-tuberculous mycobacteria can also be improved by combining the specific primers and inclusive primers of the present application, thereby improving the accuracy of the identification results. The present application does not impose further restrictions on the sequence lengths of specific primers and inclusive primers. In practical applications, when designing primers, as long as the combination of specific primers and inclusive primers can improve the resolution of strain detection and improve the accuracy of strain identification, it is within the limit range of the primer amplicon length of the present application.

[0056] In some embodiments, the target bacterial species include any one of Mycobacterium tuberculosis and non-tuberculous mycobacteria. The primer composition of the present application can amplify the specific regions of Mycobacterium tuberculosis and non-tuberculous mycobacteria, increase the proportion of amplicons in the mycobacterium-specific regions, and thus achieve "species level" identification of mycobacteria. It is understandable that the target bacterial species of the present application are not limited to mycobacterium species, but can also be other types of species. As long as it is based on the concept of primer design of the present application, the resolution of species detection is improved by combining specific primers and inclusive primers, and the accuracy of species identification is improved, the species involved can be regarded as the target bacterial species of the present application.

[0057] In some specific embodiments, the specific region includes at least one of the 16S RNA gene region, the 16S-23S rRNA intergenic region, the 23S rRNA gene region, the rpoB gene region, and the heat shock protein 65 gene region of the target bacterial species. It is understood that the specific region used to identify the typing of mycobacteria includes but is not limited to the above-mentioned specific gene regions, as long as it can achieve the distinction between mycobacteria and other bacterial species through specific amplification.

[0058] In some specific embodiments, the specific primers include a specific upstream primer as shown in SEQ ID No.1 and a specific downstream primer as shown in SEQ ID No.2.

[0059] In some specific embodiments, the inclusive primers include at least one of an inclusive upstream primer as shown in SEQ ID No.3 and an inclusive downstream primer as shown in SEQ ID No.4.

[0060] In some specific embodiments, the sequence of the specific primer also includes a first universal sequence, and the universal sequence can specifically bind to the adapter primer, thereby achieving the connection between the specific primer amplification product and the adapter sequence.

[0061] In some specific embodiments, the sequence of the inclusive primer also includes a second universal sequence, and the universal sequence can specifically bind to the adapter primer, thereby achieving the connection between the inclusive primer amplification product and the adapter sequence.

[0062] In some specific embodiments, the first universal sequence and the second universal sequence can be the same sequence.

[0063] The second aspect of the present application provides a method for constructing a sequencing library, comprising:

[0064] A nucleic acid sample of the bacterial species to be tested is obtained, and the nucleic acid sample of the bacterial species to be tested is amplified using the primer combination.

[0065] The present application creatively adopts a combination of specific primers and inclusive primers to amplify the nucleic acid sample of the test bacterial species to construct a sequencing library, which greatly reduces the proportion of non-specific amplification products from other bacterial species in the sequencing library, increases the proportion of specific amplification products that can be used for mycobacterium typing, realizes the identification of Mycobacterium tuberculosis and non-tuberculosis mycobacteria, and can also realize multiple typing identifications of non-tuberculosis mycobacteria.

[0066] In some embodiments, amplifying the nucleic acid sample of the test bacterial species using the primer composition includes:

[0067] Amplifying the nucleic acid sample of the tested bacterial species using specific primers to obtain a first amplification product;

[0068] The first amplification product and the inclusive primer are mixed and amplified to obtain a second amplification product.

[0069] In some embodiments, in order to connect the specific amplification product to the sequencing adapter, the method further comprises amplifying the first amplification product and / or the second amplification product using an adapter primer.

[0070] Specifically, the adapter primer can be combined with the first universal sequence and / or the second universal sequence to achieve the connection between the amplified product and the sequencing adapter. In the first round of PCR, specific primers are used to perform specific amplification of the specific region, and the second round of PCR uses inclusive primers to combine with the conserved region within the genus of the specific region, and amplifies a partial fragment of the specific region based on the first round of amplification products. The third round of PCR uses adapter primers to amplify the second amplification product to complete the construction of the targeted library.

[0071] In some embodiments, inclusive primers and adapter primers are amplified in the same tube, and the specific targeted library can be constructed by two rounds of PCR. Specifically, when the first amplification product is amplified using inclusive primers, the first amplification product and the adapter primers can be mixed to amplify the first amplification product, thereby completing the construction of the sequencing library by two rounds of PCR.

[0072] In some embodiments, amplifying the nucleic acid sample of the test bacterial species using the primer composition includes:

[0073] Amplifying the nucleic acid sample of the tested bacterial species using specific primers to obtain a first amplification product;

[0074] The first amplification product, at least one of the inclusive primers and the adapter primer are mixed and then amplified.

[0075] The third aspect of the present application provides a sequencing method, comprising: obtaining a sequencing library of the bacterial species to be tested, and sequencing the sequencing library of the bacterial species to be tested to obtain sequencing data of the bacterial species to be tested, wherein the sequencing library is constructed using the above method, thereby realizing the identification of Mycobacterium tuberculosis and non-tuberculous mycobacteria, and can also realize multiple typing identifications of non-tuberculous mycobacteria.

[0076] In some specific implementation schemes, sequencing is NGS sequencing. The second generation sequencing (Next-generation sequencing, NGS) is also called high-throughput sequencing. It pioneered the introduction of reversible termination ends, thereby achieving sequencing while synthesizing. During the DNA replication process, the DNA sequence is determined by capturing the special markers carried by the newly added bases. The second generation sequencing has two important characteristics:

[0077] 1. High throughput, the second generation sequencing can sequence tens or millions of DNA molecules in parallel at one time;

[0078] 2. Short read length: As the read length increases during the sequencing process, the synergy of gene cluster replication decreases, which leads to a decrease in sequencing quality. The read length of the second-generation sequencing does not exceed 500bp.

[0079] Therefore, the genome and metagenome need to be broken into small fragments and then sequenced, and then spliced ​​after sequencing is completed.

[0080] The fourth aspect of the present application provides a method for identifying a target bacterial species, the flow chart of which is as follows: Figure 1 As shown, including:

[0081] S10: obtaining sequencing data of the strain to be tested, wherein the sequencing data of the strain to be tested is obtained using the above sequencing method;

[0082] S20: Determine the type of bacterial species to be tested based on the sequencing data.

[0083] The present application utilizes the sequencing data of the strain to be tested to identify whether Mycobacterium tuberculosis or non-tuberculous mycobacteria exists, and can also perform multiple typing identifications of non-tuberculous mycobacteria based on the specific sequences of the sequencing reads uniquely aligned to the mycobacterium genome.

[0084] In some embodiments, determining the type of the strain to be tested based on the sequencing data includes:

[0085] S201: Obtain target reads that are uniquely aligned to the target gene region based on sequencing data;

[0086] S202: Determine the type of the bacterial species to be tested according to the sequence of the target reads.

[0087] Specifically, the target gene region includes at least one of the 16S RNA gene region, the 16S-23S rRNA intergenic region, the 23S rRNA gene region, the rpoB gene region and the heat shock protein 65 gene region of the target bacterial species, and the target bacterial species include at least one of Mycobacterium tuberculosis and non-tuberculous mycobacteria.

[0088] The fifth aspect of the present application provides a device for identifying target bacterial species, such as Figure 2 As shown, including:

[0089] Sequencing data acquisition module 100: used to acquire sequencing data obtained by the above sequencing method;

[0090] Bacteria species identification module 200: used to determine the type of bacteria species to be tested based on sequencing data.

[0091] The specific definition of the device for identifying the target strains can be found in the definition of the method for identifying the target strains above, which will not be repeated here. Each module in the above-mentioned device for identifying the target strains can be implemented in whole or in part by software, hardware and a combination thereof. The above-mentioned modules can be embedded in or independent of the processor in the computer device in the form of hardware, or can be stored in the memory in the computer device in the form of software, so that the processor can call and execute the operations corresponding to the above modules.

[0092] In some embodiments, a computer device is provided, which may be a server 104 or a terminal 102, and its internal structure diagram may be as follows: Figure 3 As shown. The computer device includes a processor, a memory and a communication interface connected through a system bus. When the computer device is a terminal, it also includes a display screen and an input device connected to the system bus. Among them, the processor of the computer device is used to provide computing and control capabilities. The memory of the computer device includes a non-volatile storage medium and an internal memory. The non-volatile storage medium stores an operating system and a computer program. The internal memory provides an environment for the operation of the operating system and the computer program in the non-volatile storage medium. The network interface of the computer device is used to communicate with an external terminal through a network connection. When the computer program is executed by the processor, a method for identifying a target strain is implemented. The display screen of the computer device can be a liquid crystal display screen or an electronic ink display screen, and the input device of the computer device can be a touch layer covered on the display screen, or a key, trackball or touchpad set on the computer device housing, or an external keyboard, touchpad or mouse, etc.

[0093] Those skilled in the art will understand that Figure 3 The structure shown in the figure is only a block diagram of a part of the structure related to the solution of the present application, and does not constitute a limitation on the computer device to which the solution of the present application is applied. The specific computer device may include more or fewer components than those shown in the figure, or combine certain components, or have a different arrangement of components.

[0094] The present application also provides a computer device, which includes a memory and a processor, wherein the memory stores a computer program, and the processor implements the steps of the above-mentioned method for identifying target bacteria when executing the computer program.

[0095] The present application also provides a computer-readable storage medium, wherein a computer program is stored on the computer-readable storage medium, and when the computer program is executed by a processor, the steps of the method for identifying a target bacterial species are implemented.

[0096] The present application also provides a computer program product, which includes a computer program, and when the computer program is executed by a processor, the steps of the method for identifying a target bacterial species are implemented.

[0097] It should be noted that the user information (including but not limited to user device information, user personal information, etc.) and data (including but not limited to data used for analysis, stored data, displayed data, etc.) involved in this application are all information and data authorized by the user or fully authorized by all parties.

[0098] Those skilled in the art can understand that all or part of the processes in the above-mentioned embodiments can be completed by instructing the relevant hardware through a computer program, and the computer program can be stored in a non-volatile computer-readable storage medium. When the computer program is executed, it can include the processes of the embodiments of the above-mentioned methods. Among them, any reference to the memory, database or other medium used in the embodiments provided in this application can include at least one of non-volatile and volatile memory. Non-volatile memory can include read-only memory (ROM), magnetic tape, floppy disk, flash memory, optical memory, high-density embedded non-volatile memory, resistive random access memory (ReRAM), magnetoresistive random access memory (MRAM), ferroelectric random access memory (FRAM), phase change memory (PCM), graphene memory, etc. Volatile memory can include random access memory (RAM) or external cache memory, etc. As an illustration and not limitation, RAM can be in various forms, such as static random access memory (SRAM) or dynamic random access memory (DRAM). The database involved in each embodiment provided in this application may include at least one of a relational database and a non-relational database. Non-relational databases may include distributed databases based on blockchains, etc., but are not limited to this. The processor involved in each embodiment provided in this application may be a general-purpose processor, a central processing unit, a graphics processor, a digital signal processor, a programmable logic device, a data processing logic device based on quantum computing, etc., but are not limited to this.

[0099] The implementation scheme of the present application will be described in detail below with reference to examples.

[0100] Example 1

[0101] In this embodiment, primers are designed for the HSP65 region of NTM, the target region in HSP65 is amplified using the primers, and then the target region is sequenced, and the sample to be tested is identified to the species level according to the sequence obtained in the target region. The steps of designing primers and constructing a sequencing library include:

[0102] (1) Confirm the target location;

[0103] (2) Searching for specific fragments:

[0104] Download the target reference genome sequence from a public database, and then break the downloaded reference genome; compare the broken reference genome fragments with the database, adjust the parameters to check the sequence comparison and finally select the specific target fragment; the above database can be various self-built databases or public databases such as NT database;

[0105] To find specific regions, you can also download the nucleic acid sequences of the target region at both ends corresponding to the relevant species, directly perform sequence comparison, and find the specific regions of the target species;

[0106] (3) Design specific primers on both ends of the target; primer design generally includes a forward primer sequence and a reaction primer sequence. Primer design tools such as Primer 3 can be used. The design of one or both primer regions in the forward primer and the reverse primer follows the above-mentioned specific region restrictions;

[0107] (4) Inclusive primers are designed in the conservative regions at both ends of the target. The inclusive primers should meet the NGS sequencing length requirements, that is, the target sequence can be fully sequenced when performing SE35-SE300 or PE35-PE300 sequencing; the forward primer and reverse primer of the inclusive primer must follow the above conservative region restrictions;

[0108] (5) Two or more rounds of PCR to construct a complete library.

[0109] Specifically, NTM-related genomes were downloaded from the NCBI database, low-quality genomes with short sequences were filtered out, and HSP65 gene fragments were compared to obtain NTM in the conserved region of this gene sequence. Figure 4 Similarly, the specific region of NTM at this genomic position is obtained, and the specific region should also be a conserved region within the NTM genus.

[0110] The Primer3 primer design tool was used to design specific primers and inclusive primers, but due to the limitation of NGS sequencing read length, the amplicon length was set to be less than or equal to 300bp. According to the feedback from the primer design software, inclusive primers were successfully designed in the HSP 65 region fragment. This inclusive primer can theoretically amplify all species of the genus Mycobacterium. However, the specific primer design failed. By changing the amplicon length, specific primers can be designed. The primer information is shown in Table 1 below.

[0111] Table 1

[0112]

[0113] As shown in Table 1, the amplicon size of specific primers that meet the requirements of NTM identification primers is 478bp. Conventional NGS sequencing strategies, such as PE150, cannot detect this amplicon, and there are long target regions that cannot be read, which may cause more NTM species to be unable to be distinguished and identified.

[0114] The amplicon size of inclusive primers is 300bp, and conventional sequencing strategies, such as PE150, can be directly tested and the target region can be fully read.

[0115] Example 2

[0116] Primers for amplifying the NTM HSP65 gene fragment are designed, with the 5' end of the primer being a universal sequence and the 3' end being a specific primer sequence that binds to the template. In certain embodiments, the primers do not need to be connected to the universal sequence. Detailed primer sequence information is shown in Table 2 below.

[0117] Table 2

[0118]

[0119] Nucleic acid samples of Mycobacterium tuberculosis, Mycobacterium abscessus, Mycobacterium bovis, and sputum nucleic acid extraction samples of normal persons (negative for Mycobacterium tuberculosis and non-tuberculous Mycobacterium) were taken and amplified using the primers in this embodiment. PCR reaction components were configured according to Table 3.

[0120] Table 3

[0121]

[0122] The above reaction system should be prepared on ice, and after preparation, it should be mixed and centrifuged briefly to centrifuge the liquid on the tube wall to the bottom of the tube. After the PCR reaction system is prepared, it is placed in a PCR instrument for amplification. The PCR reaction program is shown in Table 4 below.

[0123] Table 4

[0124]

[0125] The amplified product was detected on 1% agarose gel, and 3 μL of PCR product was subjected to electrophoresis at 120 V for 30 min.

[0126] like Figure 5 As shown, the specific primer pair can amplify both tuberculosis and non-tuberculosis mycobacteria, and has no amplification in negative sputum, with good specificity, but the amplicon is too long and the target region cannot be sequenced by ordinary sequencing.

[0127] like Figure 6As shown, inclusive primers can amplify both tuberculosis and non-tuberculosis mycobacteria, but they may also amplify in normal human sputum samples, that is, negative samples, and their primer specificity cannot be guaranteed.

[0128] Example 3

[0129] Sputum samples from two patients with clinical suspected tuberculosis were collected, and the sputum was liquefied with 4% NaOH and then nucleic acid was extracted. The control group used specific primers and inclusive primers for PCR amplification, and the amplification reaction and procedure were as in the previous example. The experimental group used the specific primers provided in Example 1 for PCR amplification. After the reaction was completed, the PCR reaction solution was purified using 0.8X magnetic beads and finally dissolved in 20μL TE Buffer (pH 8.0). At this time, the control group: specific primer 1P product and inclusive primer 1P product; and the experimental group: specific primer 1P product were obtained. The three groups of products were quantified by Qubit, and a certain amount of the product was taken for subsequent 2P.

[0130] The control group specific primer 1P product and inclusive primer 1P product were subjected to a second round of PCR reaction using the Kappa Ultima HF Amplification Mix, and the P5 and P7 adapters were connected to form a complete library structure. The experimental group specific primer 1P product was also subjected to a second round of PCR reaction using the Kappa Ultima HF Amplification Mix. The normal P5 and P7 primers were removed from the reaction system, and the inclusive primers were added. The inclusive primers were amplified using the specific primer products as templates, and the P5 and P7 adapters were connected to form a complete library structure. The amplification principle is as follows Figure 7 shown.

[0131] After the second round of PCR, the PCR reaction solution was purified with 0.8X magnetic beads and finally dissolved in 40 μL TEBuffer (pH 8.0). The purified product was subjected to Qubit quantification and Qseq fragment detection quality control. The quality control results of each library sequence are shown in Table 5.

[0132] After the quality control was qualified, the Illumina Miseq sequencer was used for PE150 sequencing. The sequencing experiment was operated according to the standard SOP provided by the sequencer manufacturer. After the data was taken off the machine, bioinformatics analysis was performed, low-quality reads and adapter reads were filtered to obtain clean reads, Celan reads were compared with the NT database, and the target amplification depth and non-specific proportion were counted. Among them, when calculating the non-specific proportion, the reads that were uniquely aligned to the genome of tuberculosis or non-tuberculous mycobacteria were counted as specific fragments, and the reads that were aligned to the genome of species other than tuberculosis or non-tuberculous mycobacteria were counted as non-specific fragments.

[0133] The statistical results are shown in Table 6. The majority of specific amplicon fragments obtained from the specific library and the combinatorial library were specific amplicon fragments, while the majority of the inclusive library was non-specific amplicon, i.e., background bacteria.

[0134] Table 5

[0135]

[0136] Note: raw_reads: all reads in the original sequencing data;

[0137] Q30_rate(%): Phred quality score (denoted by Q), which is the logarithm of the base error rate P, and describes the reliability of each sequenced base. If the accuracy of a base is 99.9%, the quality score is 30 (commonly known as Q30);

[0138] clean_reads: remove poor quality reads from the original sequencing data to obtain clean reads;

[0139] clean_read_rate(%): the ratio of clean reads to raw reads;

[0140] TB&NTM map_read_pair: clean reads with both ends mapped to the TB or NTM genome;

[0141] TB&NTM map_rate: the ratio of reads mapped to TB or NTM genome to clean reads;

[0142] Nonspecifc reads: reads in clean reads that are not mapped to the TB or NTM genome;

[0143] nonspecifc_rate: the ratio of reads not mapped to TB or NTM genome to clean reads;

[0144] Further data analysis was performed on the reads aligned to each library, i.e., the reads aligned to the genome of tuberculosis or non-tuberculosis mycobacteria. Reads that could only be aligned to one species were marked as uniquely aligned reads, and reads that were aligned to two or more species were marked as non-uniquely aligned reads.

[0145] Table 6

[0146]

[0147] Note: unique map_reads: reads that are uniquely mapped to the TB or NTM genome;

[0148] unique map_read_rate: the ratio of reads uniquely mapped to the TB or NTM genome to the total map reads;

[0149] TB unique map_reads: reads uniquely mapped to the TB genome;

[0150] TB unique map_read_rate: the ratio of reads uniquely mapped to the TB genome to the total map reads;

[0151] MAB unique map_reads: reads uniquely mapped to the MAB (Mycobacteroides abscessus) genome;

[0152] MAB unique map_read_rate: the ratio of reads uniquely mapped to the MAB (Mycobacteroides abscessus) genome to the total map reads;

[0153] The sequence comparison results show that no reads in the patient A specific library can be uniquely aligned to the TB or NTM genome; only one read in the patient A inclusive library can be uniquely aligned to the TB or NTM genome, specifically the TB genome; and most of the patient A's library in this application can be uniquely aligned to the TB or NTM genome, and all unique alignments are to the TB genome. The reason for the above comparison results is that the amplicon of the specific library is too long, which exceeds the sequencing read length, resulting in the target typing identification target area being unable to be measured or even unable to be measured, while the library in this application ensures specificity and makes the target typing identification target area fully measured, and reads out effective information. The above results can be used to interpret the data. The specific library of patient A can only detect the presence of mycobacteria in the sputum sample to be tested, but it cannot determine whether it is Mycobacterium tuberculosis or some other non-tuberculous mycobacteria; the inclusive library of patient A has 1 TB-specific read (that is, the only read that is aligned to the TB genome in the table), and the number of reads is too small to clearly determine whether it is purely mycobacterium; while the library of patient A's application has detected a total of 20027 TB-specific reads, which can determine that the sample to be tested is purely infected with Mycobacterium tuberculosis. The results of the library of patient A's application are consistent with the clinical results.

[0154] The experimental results of patient A were the same. No reads in patient B's specific library could be uniquely mapped to the TB or NTM genome; no reads were found in patient B's inclusive library that could be uniquely mapped to the TB or NTM genome; and most of patient B's application library could be uniquely mapped to the Mycobacteroides abscessus genome. The results of patient B's application library were consistent with the clinical results and were both diagnosed as non-tuberculous mycobacterium infection, specifically Mycobacterium abscessus infection.

[0155] The technical features of the above embodiments may be combined arbitrarily. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0156] The above embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the patent of the present application shall be subject to the attached claims.

Claims

1. Primer composition for identifying target bacterial species, It is characterized in that include: Specific primers and inclusive primers; The specific primers are used to specifically amplify the specific region of the target bacterial species, and the specific region includes the conserved region within the genus of the target bacterial species; The inclusive primer is capable of binding to a genus-conserved region within the specific region.

2. The primer composition according to claim 1, It is characterized in that The target bacterial species include at least one of Mycobacterium tuberculosis and non-tuberculous mycobacteria; Optionally, the specific region includes at least one of a 16S rRNA gene region, a 16S-23S rRNA intergenic region, a 23S rRNA gene region, an rpoB gene region, and a heat shock protein 65 gene region of the target bacterial species; Optionally, the amplified fragment length of the specific primer is greater than 300 bp; Optionally, the amplified fragment length of the inclusive primer is less than 300 bp; Optionally, the specific primers include a specific upstream primer as shown in SEQ ID No.1 and a specific downstream primer as shown in SEQ ID No.2; Optionally, the inclusive primers include at least one of an inclusive upstream primer as shown in SEQ ID No. 3 and an inclusive downstream primer as shown in SEQ ID No. 4; Optionally, the sequence of the specific primer is linked to a first universal sequence; Optionally, the sequence of the inclusive primer is linked to a second universal sequence.

3. A method for constructing a sequencing library, It is characterized in that include: Obtain a nucleic acid sample of the bacterial species to be tested, and amplify the nucleic acid sample of the bacterial species to be tested using the primer combination described in claim 1 or 2.

4. The method according to claim 3, It is characterized in that The method of amplifying the nucleic acid sample of the strain to be tested by using the primer combination of claim 1 or 2 comprises: Amplifying the nucleic acid sample of the tested bacterial species using specific primers to obtain a first amplification product; The first amplification product and the inclusive primer are mixed and amplified to obtain a second amplification product; Optionally, the method further comprises amplifying the first amplification primer or the second amplification product using a linker primer, wherein the linker primer can bind to the first universal sequence and / or the second universal sequence; or The primer composition amplifies the nucleic acid sample of the strain to be tested, comprising: Amplifying the nucleic acid sample of the tested bacterial species using specific primers to obtain a first amplification product; The first amplification product, at least one of the inclusive primers and the adapter primer are mixed and then amplified.

5. A sequencing method, It is characterized in that include: Obtaining a sequencing library of the strain to be tested, wherein the sequencing library is constructed using the method described in claim 3 or 4; The sequencing library of the bacterial species to be tested is sequenced to obtain sequencing data of the bacterial species to be tested.

6. A method for identifying a target bacterial species, It is characterized in that include: Obtaining sequencing data of the strain to be tested, wherein the sequencing data is obtained by the sequencing method according to claim 5; The type of the bacterial species to be tested is determined according to the sequencing data.

7. The method according to claim 6, It is characterized in that Determining the type of the strain to be tested according to the sequencing data comprises: Obtain target reads uniquely aligned to the target gene region according to the sequencing data; The type of the bacterial species to be tested is determined according to the sequence of the target reads, the target gene region includes at least one of the 16S RNA gene region, the 16S-23S rRNA intergenic region, the 23S rRNA gene region, the rpoB gene region and the heat shock protein 65 gene region of the target bacterial species, and the target bacterial species includes at least one of Mycobacterium tuberculosis and non-tuberculous mycobacteria.

8. A device for identifying target bacterial species, It is characterized in that include: A sequencing data acquisition module: used to acquire sequencing data of a nucleic acid sample of a strain to be tested, wherein the sequencing data is obtained according to the sequencing method according to claim 5; Bacteria species identification module: used to determine the type of bacteria to be tested based on the sequencing data.

9. A computer device comprising a memory and a processor, wherein the memory stores a computer program. It is characterized in that When the processor executes the computer program, the steps of the method according to claim 6 are implemented.

10. A computer-readable storage medium having a computer program stored thereon, It is characterized in that When the computer program is executed by a processor, the steps of the method according to claim 6 are implemented.